Merck & Co., Inc. CEDEAR Logo

Merck & Co., Inc. CEDEAR (MRK)

BCBA

Currency in ARS
48,560.00
+1,340.00 (+2.84%)

Closed

Aug 21, 2026

Day's Range

47,380.00
49,000.00

52 wk Range

21,600.00
49,000.00

Overview - MRK - Merck & Co., Inc. CEDEAR

Key Statistics

Valuation

Enterprise Value

1,434,586.16T

P/E (Trailing)

‪2.59‬

PEG Ratio

‪-0.01‬

Price / Sales (TTM)

‪179.97‬

Price / Book

‪15.50‬

EV / EBITDA

‪33,199.18‬

Profitability

Gross Margin

‪73.53%‬

Profit Margin

‪4.76%‬

Operating Margin

‪-0.24%‬

Return on Assets

‪11.86%‬

Return on Equity

‪6.96%‬

Ownership

Shares Outstanding

2.46B

Float

19.70B

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.00%‬

Price stats

Beta

‪0.21‬

50-Day Avg

‪39,852.40‬

200-Day Avg

‪35,134.20‬

Dividends

Payout Ratio

‪5.38%‬

Frequency

Quarterly

Shariah Compliance

Not Shariah Compliant

Report Date: Feb 17, 2025

Screened by Zoya using the AAOIFI methodology.

Market Cap - MRK - Merck & Co., Inc. CEDEAR

Peers - MRK - Merck & Co., Inc. CEDEAR

Peer Comparison

Compared with companies in Drug Manufacturers - General listed on BCBA.

Profile Summary - MRK - Merck & Co., Inc. CEDEAR

About

Merck & Co., Inc. CEDEAR is an Argentine depositary receipt that represents an economic interest in shares of Merck & Co., Inc., a global biopharmaceutical company focused on prescription medicines, vaccines, and animal health products. Its primary purpose is to provide local investors peso-denominated access to…

SectorHealthcare
IndustryDrug Manufacturers - General
Employees73K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.